Replies to post #585 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[genisi]

Drug shortage in Israel is not that bad as far as I know because many patients switched to PLX's drug. Normally drugs are approved in Israel shortly after being approved by the FDA or the EMEA and hardly ever before, so I don't see this happens.